Wed, Sep 18, 2024
Biocon has announced that LIC has increased its shareholding in their equity shares to 5.023 per cent.
More >
Thu, Aug 22, 2024
In a buoyant market mood after the release of the latest Fed meeting minutes, Indian equities are largely witnessing broad-based buying as the likely interest rate-cut will see foreign funds inflow into India.
Tue, Aug 06, 2024
Lupin Q1 FY25 Results Preview: Mumbai-headquartered drug maker Lupin is estimated to register a 30 per cent year-on-year jump in its consolidated net profit for the April-June period. Read on to know what else you can expect in the pharmaceutical company's upcoming earnings report.
Tue, Feb 28, 2023
Nifty Pharma and BSE Healthcare indices were trading below the flat line as most drug makers like Cipla, Biocon, Dr Reddy’s, and Alkem among others were a mixed bag
Wed, Dec 14, 2022
The volatility seen in 2022 is likely to carry forward till the first half of the next year, WhiteOak Capital, Chief Executive Officer, Aashish P Sommaiyaa said while speaking to Zee Business.
Wed, Nov 09, 2022
Divi’s Laboratories stock has corrected from highs of Rs 3,829.10, it hit on 1 November, witnessing a fall of Rs 545 or 17%
Fri, Oct 28, 2022
Technical analyst Nilesh Jain suggests an avoid in this scrip citing that the stock has moved significantly in last few trading sessions
Mon, Oct 03, 2022
In contrast to the benchmark indices, the pharma and healthcare indices surged in a weak market.
Thu, Sep 29, 2022
The Nifty Pharma is one of the top sectoral gainers as compared to a 0.16% fall in the Nifty, it jumped by 3.5% this week against to 1.5% fall in the benchmark index.
Sat, Apr 02, 2022
The broader markets have outperformed the benchmarks during April Series, as Nifty Midcap grew by 5.4 per cent and small-cap 6 per cent on an average of 5 years, the report noted.
Mon, Dec 27, 2021
Leading the maximum surge in the markets, the pharma stocks from across segment are on the roll a day after Prime Minister Narendra Modi on Saturday announced precautionary shorts in the wake of Omicron, a new Covid variant, spread in the country.
Spotlight was on Nifty Pharma as the index was the top gainer around this time. It was trading at 13,710.80 and near its intraday high, up 1.6 per cent from the Friday closing level
Wed, Oct 27, 2021
In the 20-share index, 17 advanced while 3 declined. The 52-week high is 14,938.25. The biggest gainers were Divi’s Laboratories Limited followed by Sun Pharmaceuticals Industries Limited and Strides Pharma Limited which were up almost 2.9, 2.1 and 2.1 per cent respectively
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
